Literature DB >> 21292344

Regulation of T cell activation by TLR ligands.

Hans-Heinrich Oberg1, Matthias Juricke, Dieter Kabelitz, Daniela Wesch.   

Abstract

Regulatory T cells (Treg) maintain peripheral tolerance and play a critical role in the control of the immune response in infection, tumor defense, organ transplantation and allergy. CD4(+)CD25(high) Treg suppress the proliferation and cytokine production of CD4(+)CD25(-) responder T cells. The suppression requires cell-cell-contact and/or production of inhibitory cytokines like IL-10 or TGF-β. The current knowledge about the regulation of Treg suppressive function is limited. Toll-like receptors (TLR) are widely expressed in the innate immune system. They recognize conserved microbial ligands such as lipopolysaccharide, bacterial lipopeptides or viral and bacterial RNA and DNA. TLR play an essential role in innate immune responses and in the initiation of adaptive immune responses. However, certain TLR are also expressed in T lymphocytes, and the respective ligands can directly modulate T cell function. TLR2, TLR3, TLR5 and TLR9 act as costimulatory receptors to enhance proliferation and/or cytokine production of T-cell receptor-stimulated T lymphocytes. In addition, TLR2, TLR5 and TLR8 modulate the suppressive activity of naturally occurring CD4(+)CD25(high) Treg. The direct responsiveness of T lymphocytes to TLR ligands offers new perspectives for the immunotherapeutic manipulation of T cell responses. In this article we will discuss the regulation of Treg and other T cell subsets by TLR ligands.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292344     DOI: 10.1016/j.ejcb.2010.11.012

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  35 in total

Review 1.  T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival.

Authors:  Mohammad A Khan; Sana Moeez; Suhail Akhtar
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

2.  Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death.

Authors:  Bridget Larkin; Vladimir Ilyukha; Maxim Sorokin; Anton Buzdin; Edouard Vannier; Alexander Poltorak
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

Review 3.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 4.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

Review 5.  Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.

Authors:  David W Scott; Jay N Lozier
Journal:  Br J Haematol       Date:  2011-11-07       Impact factor: 6.998

6.  Stimulatory Toll-like receptor 2 suppresses restraint stress-induced immune suppression.

Authors:  Dan Hu; James Denney; Manfei Liang; Avani Javer; Xiaohua Yang; Ruiliang Zhu; Deling Yin
Journal:  Cell Immunol       Date:  2013-05-31       Impact factor: 4.868

Review 7.  Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells.

Authors:  Pushpa Pandiyan; Jinfang Zhu
Journal:  Cytokine       Date:  2015-07-10       Impact factor: 3.861

8.  MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen.

Authors:  Katja Fiedler; Enikö Kokai; Susanne Bresch; Cornelia Brunner
Journal:  Am J Blood Res       Date:  2013-05-05

9.  Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.

Authors:  Nicole M Chapman; Mahmood Y Bilal; Noemi Cruz-Orcutt; Cory Knudson; Sofia Madinaveitia; Jonathan Light; Jon C D Houtman
Journal:  Cell Signal       Date:  2012-12-05       Impact factor: 4.315

10.  CX3CR1(+) B cells show immune suppressor properties.

Authors:  Zhiqiang Wu
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.